SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-225297
Filing Date
2022-08-19
Accepted
2022-08-19 16:16:00
Documents
12
Period of Report
2022-08-16
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d389791d8k.htm   iXBRL 8-K 34674
  Complete submission text file 0001193125-22-225297.txt   160835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA endp-20220816.xsd EX-101.SCH 2849
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE endp-20220816_lab.xml EX-101.LAB 18691
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endp-20220816_pre.xml EX-101.PRE 11682
6 EXTRACTED XBRL INSTANCE DOCUMENT d389791d8k_htm.xml XML 3546
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 221180987
SIC: 2834 Pharmaceutical Preparations